GLP-1 TV · News & media · 5 videos
CBS News
@CBSNews on YouTube ↗CBS News is a YouTube channel of news and media coverage of GLP-1 medications, with 7.1M subscribers and a verified badge. GLP-1 TV holds 5 of its videos, 79.5K views between them, the newest from Jun 2026.
- Medications covered
- Ozempic (2), Wegovy (1), Retatrutide (1)
- Topics that come up most
- Exercise and strength, Muscle loss, Side effects, Food noise and cravings, Alcohol, Stopping and maintenance
3:58What to know about GLP-1 drugs and muscle lossCBS NewsDetails
This CBS News segment is an interview with Dylan Scott, a senior correspondent at Vox, about muscle loss and weakness reported by people taking GLP-1 weight loss drugs. The host opens with a KFF poll finding that one in eight US adults are currently taking a GLP-1 drug.
- Side effects mentioned: muscle loss
- Who is speaking: News or media
4:45Ozempic and Wegovy may reduce alcohol cravings, some users sayCBS NewsDetails4 key moments
In this CBS News segment from August 2023, a host interviews Dr. Tamika Henry, who is introduced as the founder of the Unlimited Health Institute, a preventative medicine practice based in California.
- Who is speaking: News or media
2:51Stopping weight loss drugs can cause rapid weight gain, reverse health benefits, new study findsCBS NewsDetails3 key moments
This CBS News segment covers a new study in the BMJ on what happens when people stop taking GLP-1 weight loss drugs.
- Who is speaking: News or media
3:08High cost of drugs like Ozempic a struggle for lower-income patientsCBS NewsDetails
This CBS News segment is a short interview about why GLP-1 drugs such as Ozempic are hard to afford and obtain, especially for lower-income people.
- Prices mentioned: $1300 a month
- Who is speaking: News or media
3:19Doctors caught promoting unregulated weight-loss drug retatrutide, CBS News findsCBS NewsDetails
According to the video, a CBS News investigation looked at retatrutide, an injectable drug that is popular online under the nickname "Retatide" and is described as promising to curb hunger, shed fat and retain muscle.
- Who is speaking: News or media
Where semaglutide costs least today
The three cheapest partner programs for semaglutide, all in per month, checked weekly. Brand Ozempic and compounded versions are different products; each row says which it is.
What each CBS News video covers
The opening line of our summary for each video, most-watched first.
- What to know about GLP-1 drugs and muscle loss
This CBS News segment is an interview with Dylan Scott, a senior correspondent at Vox, about muscle loss and weakness reported by people taking GLP-1 weight loss drugs.
51.9K views · Dec 2025 - Ozempic and Wegovy may reduce alcohol cravings, some users say
In this CBS News segment from August 2023, a host interviews Dr. Tamika Henry, who is introduced as the founder of the Unlimited Health Institute, a preventative medicine practice based in California.
10.4K views · Aug 2023 - Stopping weight loss drugs can cause rapid weight gain, reverse health benefits, new study finds
This CBS News segment covers a new study in the BMJ on what happens when people stop taking GLP-1 weight loss drugs.
9.1K views · Jan 2026 - High cost of drugs like Ozempic a struggle for lower-income patients
This CBS News segment is a short interview about why GLP-1 drugs such as Ozempic are hard to afford and obtain, especially for lower-income people.
4.9K views · May 2024 - Doctors caught promoting unregulated weight-loss drug retatrutide, CBS News finds
According to the video, a CBS News investigation looked at retatrutide, an injectable drug that is popular online under the nickname "Retatide" and is described as promising to curb hunger, shed fat and retain muscle.
3.3K views · Jun 2026
Watched them? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.